2016 Fiscal Year Final Research Report
Elucidation of drug resistance of Wnt5a positive breast cancer and its application to anticancer therapy
| Project/Area Number |
26861049
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
General surgery
|
|---|
| Research Institution | Hiroshima University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2014-04-01 – 2017-03-31
|
| Keywords | Wnt5a / 分子標的治療 |
|---|
| Outline of Final Research Achievements |
Relationships were examined between Wnt5a expression and clinicopathologic factors in 178 consecutive cases of invasive breast cancer.(1)Wnt5a was positively expressed in 69 cases (39%) among 178 cases of invasive breast cancer. Wnt5a expression was strongly correlated with being estrogen receptor (ER)-positive.(2)Analysis of the relationship between Wnt5a expression and malignancy in exclusively 153 cases of ER-positive breast cancer led to detection of significant correlations with lymph node metastasis, nuclear grade, and lymphatic invasion. (3)Relapse-free survival was shorter in cases of Wnt5a-positive breast cancer compared to Wnt5a-negative breast cancer cases. Base on our data, Wnt5a expression can be a prognostic factor in ER-positive breast cancer.
|
| Free Research Field |
乳癌
|
